Gene expression profiling of EGFR positive cancer
    1.
    发明申请
    Gene expression profiling of EGFR positive cancer 失效
    EGFR阳性癌基因表达谱

    公开(公告)号:US20050019785A1

    公开(公告)日:2005-01-27

    申请号:US10714195

    申请日:2003-11-14

    IPC分类号: C12Q1/68

    摘要: The present invention concerns prognostic markers associated with EGFR positive cancer. In particular, the invention concerns prognostic methods based on the molecular characterization of gene expression in paraffin-embedded, fixed tissue samples of EGFR-expressing cancer, which allow a physician to predict whether a patient is likely to respond well to treatment with an EGFR inhibitor.

    摘要翻译: 本发明涉及与EGFR阳性癌症相关的预后标志物。 特别地,本发明涉及基于在石蜡包埋的EGFR表达癌症的固定组织样品中的基因表达的分子表征的预后方法,其允许医师预测患者是否可能对EGFR抑制剂的治疗反应良好 。